Company Filing History:
Years Active: 2022
Title: Pablo Gabriel Cironi Lopez: Innovator in Protein Therapeutics
Introduction
Pablo Gabriel Cironi Lopez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of protein therapeutics, focusing on innovative methods to harness the potential of naturally occurring proteins while minimizing their toxicity.
Latest Patents
Pablo holds a patent for "Chimeric activators: quantitatively designed protein therapeutics and uses thereof." This invention provides methods for utilizing proteins that occur naturally in humans, which can have serious but finite toxicity. The invention employs a quantitative systems-biological and structural approach to design a class of chimeric proteins that avoid the toxicity of traditional protein drugs while retaining their desired activities. Specifically, these chimeric proteins contain a variant form of a natural protein fused to a targeting moiety, allowing for targeted delivery of signals, such as the induction of apoptosis, to specific cells without causing generalized toxic effects.
Career Highlights
Pablo is affiliated with Harvard College, where he continues to advance his research in protein therapeutics. His work is characterized by a commitment to innovation and the development of safer therapeutic options.
Collaborations
Pablo has collaborated with esteemed colleagues, including Pamela Ann Silver and David G Miguez, contributing to a rich environment of research and innovation.
Conclusion
Pablo Gabriel Cironi Lopez is a pioneering inventor whose work in chimeric protein therapeutics represents a significant advancement in the field. His innovative approaches aim to improve the safety and efficacy of protein-based treatments, showcasing the potential of targeted therapies in modern medicine.